PRVCF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Aug 8 closing price
Capitalization
14.54M
PTIX
Price
$2.78
Change
-$0.05 (-1.77%)
Updated
Aug 11, 04:57 PM (EDT)
Capitalization
2.46M
Interact to see
Advertisement

PRVCF vs PTIX

Header iconPRVCF vs PTIX Comparison
Open Charts PRVCF vs PTIXBanner chart's image
PreveCeutical Medical
Price$0.03
Change-$0.00 (-0.00%)
Volume$2K
Capitalization14.54M
Protagenic Therapeutics
Price$2.78
Change-$0.05 (-1.77%)
Volume$150
Capitalization2.46M
PRVCF vs PTIX Comparison Chart in %
Loading...
PRVCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRVCF vs. PTIX commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRVCF is a Hold and PTIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (PRVCF: $0.03 vs. PTIX: $2.83)
Brand notoriety: PRVCF and PTIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRVCF: 5% vs. PTIX: 27%
Market capitalization -- PRVCF: $14.54M vs. PTIX: $2.46M
PRVCF [@Biotechnology] is valued at $14.54M. PTIX’s [@Biotechnology] market capitalization is $2.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRVCF’s FA Score shows that 0 FA rating(s) are green whilePTIX’s FA Score has 1 green FA rating(s).

  • PRVCF’s FA Score: 0 green, 5 red.
  • PTIX’s FA Score: 1 green, 4 red.
According to our system of comparison, both PRVCF and PTIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRVCF’s TA Score shows that 5 TA indicator(s) are bullish while PTIX’s TA Score has 4 bullish TA indicator(s).

  • PRVCF’s TA Score: 5 bullish, 4 bearish.
  • PTIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRVCF is a better buy in the short-term than PTIX.

Price Growth

PRVCF (@Biotechnology) experienced а +6.51% price change this week, while PTIX (@Biotechnology) price change was +4.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRVCF($14.5M) has a higher market cap than PTIX($2.46M). PRVCF YTD gains are higher at: 46.739 vs. PTIX (-58.746). PRVCF has higher annual earnings (EBITDA): -1.36M vs. PTIX (-5.18M). PTIX has more cash in the bank: 873K vs. PRVCF (5.48K). PTIX has less debt than PRVCF: PTIX (420K) vs PRVCF (4.6M). PRVCF (0) and PTIX (0) have equivalent revenues.
PRVCFPTIXPRVCF / PTIX
Capitalization14.5M2.46M590%
EBITDA-1.36M-5.18M26%
Gain YTD46.739-58.746-80%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.48K873K1%
Total Debt4.6M420K1,095%
FUNDAMENTALS RATINGS
PRVCF vs PTIX: Fundamental Ratings
PRVCF
PTIX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3990
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTIX's Valuation (22) in the null industry is somewhat better than the same rating for PRVCF (87). This means that PTIX’s stock grew somewhat faster than PRVCF’s over the last 12 months.

PTIX's Profit vs Risk Rating (100) in the null industry is in the same range as PRVCF (100). This means that PTIX’s stock grew similarly to PRVCF’s over the last 12 months.

PTIX's SMR Rating (100) in the null industry is in the same range as PRVCF (100). This means that PTIX’s stock grew similarly to PRVCF’s over the last 12 months.

PRVCF's Price Growth Rating (39) in the null industry is somewhat better than the same rating for PTIX (90). This means that PRVCF’s stock grew somewhat faster than PTIX’s over the last 12 months.

PRVCF's P/E Growth Rating (100) in the null industry is in the same range as PTIX (100). This means that PRVCF’s stock grew similarly to PTIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRVCFPTIX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
PRVCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYLQF1.730.63
+56.91%
HYLQ STRATEGY CORP.
OBYCF16.45N/A
N/A
Obayashi Corp.
SPHDF18.40N/A
N/A
Santhera Pharmaceuticals Holdings Ltd.
RHEPA0.40N/A
N/A
Regional Health Properties, Inc.
EXALF139.41-4.59
-3.19%
EXAIL TECHNOLOGIES

PRVCF and

Correlation & Price change

A.I.dvisor tells us that PRVCF and GLMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRVCF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRVCF
1D Price
Change %
PRVCF100%
+3.85%
GLMD - PRVCF
22%
Poorly correlated
+5.84%
ARTL - PRVCF
22%
Poorly correlated
-7.53%
TCRT - PRVCF
21%
Poorly correlated
-5.00%
MLEC - PRVCF
21%
Poorly correlated
N/A
PTIX - PRVCF
14%
Poorly correlated
+0.35%
More

PTIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTIX has been loosely correlated with ARMP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PTIX jumps, then ARMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTIX
1D Price
Change %
PTIX100%
+0.35%
ARMP - PTIX
45%
Loosely correlated
+2.11%
CTXR - PTIX
26%
Poorly correlated
-4.65%
TNGX - PTIX
26%
Poorly correlated
N/A
BPTSY - PTIX
24%
Poorly correlated
N/A
BOLT - PTIX
24%
Poorly correlated
N/A
More